2024-11-15 Emeren Group Ltd HaiPress

NORWALK,Conn.,Nov. 15,2024 -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL),a leading global solar project developer,owner,and operator,today announced its unaudited financial results for the third quarter ended September 30,2024. Emeren's third quarter 2024 financial results and management commentary can be found by accessing the Company's shareholder letter on the quarterly results page of the Investor Relations section of Emeren Group Ltd's website at https://ir.emeren.com/.
Emeren Group Ltdwill host a conference call today to discuss the results.
Conference Call Details
We will host a conference call today to discuss our third quarter 2024 business and financial results.The call is scheduled to begin at4:30 p.m. U.S. Eastern Time on Thursday,November 14,2024.
Please register in advance to join the conference call using the link provided below and dial in 10 minutes before the call is scheduled to begin. Conference call access information will be provided upon registration.
Participant Online Registration:
https://register.vevent.com/register/BI45573df6da5b45ddbf1d1490be2da2dc
Audio-only Webcast:
https://edge.media-server.com/mmc/p/4s2et8tm
Additionally,an archived webcast of the conference call will be available on the Investor Relations section of Emeren Group Ltd's website at https://ir.emeren.com/.
About Emeren Group Ltd
Emeren Group Ltd (NYSE: SOL),a renewable energy leader,showcases a comprehensive portfolio of solar projects and Independent Power Producer (IPP) assets,complemented by a significant global Battery Energy Storage System (BESS) capacity. Specializing in the entire solar project lifecycle — from development through construction to financing — we excel by leveraging local talent in each market,ensuring our sustainable energy solutions are at the forefront of efficiency and impact. Our commitment to enhancing solar power and energy storage underlines our dedication to innovation,excellence,and environmental responsibility. For more information,go to www.emeren.com.
For investor and media inquiries,please contact:
Emeren Group Ltd - Investor Relations
+1 (925) 425-7335
ir@emeren.com
The Blueshirt Group
Gary Dvorchak
+1 (323) 240-5796
gary@blueshirtgroup.co
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map